The most efficient way to measure your GLP-1 analogs’ levels using ELISA assays

Glucagon-like peptide-1 agonist (GLP-1 agonist) is a class of drugs that reduce blood glucose and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1, which is released from the gut after eating. GLP-1 is the target of many synthetic drugs on the market, initially developed in the treatment of type II diabetes, including:

Liraglutide: Reduces meal-related hyperglycemia by delaying gastric emptying

Product S-1502

Dulaglutide: Acts similarly to GLP-1, increasing the amount of insulin released by the pancreas

Product S-1551

Lixisenatide: Helps the beta cells of the pancreas to secrete insulin in response to high blood sugar

Product S-1509

Semaglutide: GLP-1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus

Product S-1530


At BMA, we offer competitive ELISA kits for the determination of GLP-1 analogs. Check out our catalog at and get in contact with us at We will be happy to assist you!

Your BMA Team



Author: Dr. Sonia Accossato

Copyright © BMA Biomedicals 2023